Xellar Biosystems develops a 3D Bio Intelligence platform combining organ-on-chip systems, laboratory automation, high-content imaging, multi-omics analysis, and AI-driven biological modeling.
The company focuses on creating human-relevant biological data infrastructure and virtual cell technologies to accelerate next-generation drug discovery.